Expanding footprint and taking Bangladesh to the world
With a global footprint in more than 50 countries and counting, Beximco Pharma is now hailed as one of the largest exporters of medicines in Bangladesh. Beximco Pharma began its journey in the late 70s and, within a short span of time, it became a leading pharmaceuticals manufacturer in Bangladesh. The flagship company of the Beximco Group, which is the largest private sector industrial conglomerate in the country, Beximco Pharma specialises in the manufacturing of Pharmaceutical Formulations and Active Pharmaceutical Ingredients (APIs). It has the highest number of international approvals in the country in the pharma sector and has also won the National Export Trophy (Gold) a record four times. Its pool of selected customers includes globally reputed hospitals and institutes. It has become the first pharmaceutical company in the country to enter the regulated markets of EU and Australia and has a sound track record of working with global MNCs.
Key Features
1. Beximco Pharmaceuticals Ltd is the only Bangladeshi company to get listed on the AIM of London Stock Exchange
2. Beximco Pharmaceuticals Ltd is the largest producer of metered dose inhalers (MDIs) and other specialty drugs in the country. They currently produce more than 300 generics in over 500 different strengths and dosage forms
3. Already accredited by the regulatory authorities of Australia, EU, Canada and Latin America, among others
